845 related articles for article (PubMed ID: 16600306)
61. Experimental axonopathy induced by immunization with Campylobacter jejuni lipopolysaccharide from a patient with Guillain-Barré syndrome.
Caporale CM; Capasso M; Luciani M; Prencipe V; Creati B; Gandolfi P; De Angelis MV; Di Muzio A; Caporale V; Uncini A
J Neuroimmunol; 2006 May; 174(1-2):12-20. PubMed ID: 16516981
[TBL] [Abstract][Full Text] [Related]
62. Ganglioside GM1 mimicry in Campylobacter strains from sporadic infections in the United States.
Nachamkin I; Ung H; Moran AP; Yoo D; Prendergast MM; Nicholson MA; Sheikh K; Ho T; Asbury AK; McKhann GM; Griffin JW
J Infect Dis; 1999 May; 179(5):1183-9. PubMed ID: 10191221
[TBL] [Abstract][Full Text] [Related]
63. Anti-GalNAc-GD1a antibody-associated Guillain-Barré syndrome with a predominantly distal weakness without cranial nerve impairment and sensory disturbance.
Hao Q; Saida T; Yoshino H; Kuroki S; Nukina M; Saida K
Ann Neurol; 1999 Jun; 45(6):758-68. PubMed ID: 10360768
[TBL] [Abstract][Full Text] [Related]
64. Lipopolysaccharides of a Campylobacter coli isolate from a patient with Guillain-Barré syndrome display ganglioside mimicry.
Bersudsky M; Rosenberg P; Rudensky B; Wirguin I
Neuromuscul Disord; 2000 Mar; 10(3):182-6. PubMed ID: 10734265
[TBL] [Abstract][Full Text] [Related]
65. [Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni enteritis].
Tsuda N; Negoro K; Morimatsu M; Saito K; Yuki N
Rinsho Shinkeigaku; 1995 Feb; 35(2):208-10. PubMed ID: 7781242
[TBL] [Abstract][Full Text] [Related]
66. Serum anti-GQ1b IgG antibodies recognize surface epitopes on Campylobacter jejuni from patients with Miller Fisher syndrome.
Jacobs BC; Endtz H; van der Meché FG; Hazenberg MP; Achtereekte HA; van Doorn PA
Ann Neurol; 1995 Feb; 37(2):260-4. PubMed ID: 7531419
[TBL] [Abstract][Full Text] [Related]
67. [Antibody response following Campylobacter infections determined by ELISA].
Engberg JH; Strid MA; Mølbak K; Krogfelt KA
Ugeskr Laeger; 2003 Jun; 165(24):2485-6. PubMed ID: 12872469
[TBL] [Abstract][Full Text] [Related]
68. [Campylobacter jejuni enteritis and Guillain-Barré syndrome].
Yuki N
Rinsho Shinkeigaku; 1999 Jan; 39(1):17-8. PubMed ID: 10377788
[TBL] [Abstract][Full Text] [Related]
69. Current cases in which epitope mimicry is considered a component cause of autoimmune disease: Guillain-Barré syndrome.
Yuki N
Cell Mol Life Sci; 2000 Apr; 57(4):527-33. PubMed ID: 11130452
[TBL] [Abstract][Full Text] [Related]
70. [Axonal Guillain-Barré syndrome associated with anti-GalNAc-GD1a antibody subsequent to Campylobacter jejuni (PEN 43) enteritis].
Ihara Y; Saito K; Yoshimoto S; Hayabara T; Yuki N
Rinsho Shinkeigaku; 1995 Aug; 35(8):901-3. PubMed ID: 8665735
[TBL] [Abstract][Full Text] [Related]
71. Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome.
Sinha S; Prasad KN; Pradhan S; Jain D; Jha S
Trans R Soc Trop Med Hyg; 2004 Jun; 98(6):342-6. PubMed ID: 15099989
[TBL] [Abstract][Full Text] [Related]
72. Campylobacter jejuni infection in Guillain-Barré syndrome: a prospective case control study in a tertiary care hospital.
Sharma A; Lal V; Modi M; Vaishnavi C; Prabhakar S
Neurol India; 2011; 59(5):717-21. PubMed ID: 22019657
[TBL] [Abstract][Full Text] [Related]
73. Antibodies to gangliosides in Guillain-Barré syndrome: specificity and relationship to clinical features.
Gregson NA; Koblar S; Hughes RA
Q J Med; 1993 Feb; 86(2):111-7. PubMed ID: 8464986
[TBL] [Abstract][Full Text] [Related]
74. Preceding infections and anti-ganglioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective case-control study.
Sinha S; Prasad KN; Jain D; Pandey CM; Jha S; Pradhan S
Clin Microbiol Infect; 2007 Mar; 13(3):334-7. PubMed ID: 17391394
[TBL] [Abstract][Full Text] [Related]
75. [Clinical utility of measurement for anti-GM1 and anti-GQ1b antibodies].
Tagawa Y; Matsumoto Y; Yuki N
No To Shinkei; 1998 Sep; 50(9):849-53. PubMed ID: 9789308
[TBL] [Abstract][Full Text] [Related]
76. [Guillain-Barré syndrome of axonal type, Campylobacter jejuni infection and anti-ganglioside GM1 antibodies].
Attarian S; Bonnefoi-Kyriacou B; Gayraud D; Mignard P; Boucraut J; Pouget J; Viallet F
Rev Neurol (Paris); 1997 Apr; 153(3):205-8. PubMed ID: 9296136
[TBL] [Abstract][Full Text] [Related]
77. Longitudinal changes of anti-ganglioside antibodies before and after Guillain-Barré syndrome onset subsequent to Campylobacter jejuni enteritis.
Odaka M; Koga M; Yuki N; Susuki K; Hirata K
J Neurol Sci; 2003 Jun; 210(1-2):99-103. PubMed ID: 12736097
[TBL] [Abstract][Full Text] [Related]
78. Anti-ganglioside GM1 antibodies in Guillain-Barré syndrome and their relationship to Campylobacter jejuni infection.
Rees JH; Gregson NA; Hughes RA
Ann Neurol; 1995 Nov; 38(5):809-16. PubMed ID: 7486873
[TBL] [Abstract][Full Text] [Related]
79. Bacterial infections in Guillain-Barré and Fisher syndromes.
Yuki N; Koga M
Curr Opin Neurol; 2006 Oct; 19(5):451-7. PubMed ID: 16969154
[TBL] [Abstract][Full Text] [Related]
80. Utility of serum Campylobacter specific antibodies in determining prior Campylobacter infection in neurological disease.
Taylor BV; Williamson J; Jones D; Coleman D; Luck J; McGregor A
J Clin Neurosci; 2007 Feb; 14(2):116-21. PubMed ID: 17107803
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
